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FJHN are caused by lack of normal THP or by the presence of
abnormal THP.
We are one of two groups to generate THP-deficient
(THP/) mice by the technique of homologous recombina-
tion.4 In this study, we investigated if absence of THP in mice
leads to findings similar to those associated with human
mutations of THP. We selected age- and gender-matched
THP/ (n¼ 10) and THPþ /þ (n¼ 10) mice, and allowed
them to receive normal food and drink for 3 years. The mice
were assessed for weight, feeding behavior, and physical
activity. Mice were killed using carbon dioxide narcosis and
dissected. All visceral organs were examined for gross
pathology, and kidneys were processed for histology. The
kidney sections were stained with hematoxylin and eosin,
periodic acid schiff, and Masson’s trichrome stains. A renal
pathologist examined the slides in a blinded manner.
Results showed that there was no difference between the
groups (THP/ and THPþ /þ mice) in their level of
physical activity, weight gain, growth, and general health.
Renal histology was normal in all mice. There were no areas
of fibrosis or cystic change in the cortex or medulla in kidney
sections from either group of mice (Figure 1).
Our results demonstrate that the mere absence of THP is
not sufficient to cause histological changes associated with
MCKD2/FJHN in mice up to 3 years of age.
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Vascular injury mediated
by calcineurin inhibitors:
Contribution of rheological
factors?
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To the Editor: In a recent Nephrology Forum, an interesting
survey of endothelial dysfunction mediated by calcineurin
inhibitors and the cellular mechanisms leading to it is given
by Lamas.1 This dysfunction leads to an increased vascular
resistance and hypertension. However, an unmentioned
factor could also contribute to this endothelial dysfunction.
Changes in blood rheology can directly influence the forces
on the vessel wall. Shear stresses can influence endothelial cell
morphology and function. A decreased erythrocyte deform-
ability has been found in patients using cyclosporin, as well as
a higher plasma viscosity, fibrinogen level, and erythrocyte
aggregation.2,3 These rheological disturbances could con-
tribute to endothelial dysfunction: on the other hand, it
could also be suggested that disturbances of the endothelium
could contribute to rheological alterations. The endothelium
and blood could have an interesting interplay in this
respect.
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To the Editor: We read with interest the recent article
in Kidney International by Kim et al.1 concerning childhood
nephrotic syndrome. We would like to bring to
their attention our report from nearly 20 years ago
of a cohort of 60 children with initially steroid-responsive
nephritic.2 Forty-nine (82%) had a frequently relapsing or
steroid-dependent course. Twenty of these children were
treated with cyclophosphamide owing to unacceptable
steroid toxicity; all achieved a complete remission that was
sustained in 70% of the children over a mean of 9 years of
additional follow-up, whereas 30% had one or more
subsequent relapse. Of the 29 children not treated with
cyclophosphamide, 52% continued to relapse, whereas 48%
went into a remission that was sustained for between 3 and
16 years, despite the earlier frequently relapsing/steroid-
dependent course. All 20 of the cyclophosphamide-treated
children had kidney biopsies: 10 had minimal change disease;
of these, nine had a permanent remission induced. Six had
focal sclerosis and four had mesangial proliferation; of these,
only five had permanent remission. None of the 60 children
developed renal insufficiency or hypertension. Siegel et al.3
had also earlier reported the frequent occurrence of focal
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sclerosis and mesangial proliferation in frequently relapsing/
steroid-dependent nephrotic syndrome.
Thus, it is not so clear that steroid resistance among
children with initially steroid-responsive nephrotic syndrome
is more common now compared to 20–30 years ago.
Furthermore, although the prevalence of lesions other than
minimal change among all children with nephrotic syndrome
or with initially steroid-resistant nephrotic syndrome may be
increasing,4 it is also not clear that lesions other than
minimal change disease in those with steroid responsiveness
and subsequent development of steroid resistance have
become more common.
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Citrate therapy in Dent’s disease
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To the Editor: Cebotaru et al.1 have shown that a high citrate
diet prevents the tubulointerstitial damage in a mouse model
of Dent’s disease. The implicit hypothesis was that the
increase in citraturia prevents calcium crystallization and the
secondary renal damage. The results are very interesting
particularly in reference to an orphan disease as Dent’s
disease. However, an alternative explanation of these findings
may be proposed. The problem is whether the knockout
animals have a metabolic acidosis. I think they have it, as
suggested by the following observations. As dietary citrate
ameliorates metabolic acidosis, the intracellular (including
tubular cell) acidosis should also improve. The latter would
translate in an increased citraturia, which indeed is observed
in the knockout animals although not statistically significant.
Correction by citrate of metabolic acidosis in the mutated
animals would also explain why the urinary pH is lower than
in the wild-type animals. Interestingly, these findings may
also be explained from a different standpoint. Actually,
Cheema-Dhadli et al.2 have shown that the earlier response
to an alkali load in normal rats is a decline in the excretion
of NH4
þ followed by an increase in the excretion of citrate.
If the knockout animals have metabolic acidosis, an increased
ammoniogenesis is expected, which might be one of the
triggers of the renal damage.3 Thus, reduction of renal
ammoniogenesis by the alkaline (citrate) load could prevent
chronic tubulointerstitial injuries as shown by the Hostetters3
after their landmark studies on the pathogenic role of
ammonia in the progression of chronic nephropathies.
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Response to citrate therapy in
Dent’s disease
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The authors1 suggest another interpretation of our data,
the major fact being that there is an acidic environment
in the ClCn-5 knockout (ko) mouse kidney. We do agree
with the authors that as renal failure progresses, it is likely
that the ClCn-5 ko mice have metabolic acidosis, but we
do not think younger ko mice without renal failure have
significant metabolic acidosis based on the following
information: (1) The wild-type and ClCn-5 ko mice show
no significant difference in citrate excretion on either diet.
(2) On a zero citrate diet, the wild-type and ClCn-5 ko
mice have no difference in urinary pH (pH of 5.94 and
6.03, respectively). (3) The wild-type mice have an alkaline
pH on the high citrate diet (pH 6.79) compared to the low
citrate diet, but the ClCn-5 ko mice do not have an
alkalization of urine pH (pH 6.01) compared to a no citrate
diet (pH 6.03). (4) On a high citrate diet, there is not a
difference in blood pH or blood gases for wild-type and
ClCn-5 ko mice (unpublished data). From these data, we
conclude that the delay in renal failure in ClCn-5 ko mice
on a high citrate diet is not caused by the amelioration
of the acidic environment of the kidney, but from the
addition of citrate to the diet.
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